BILIARY TRACT CARCINOMA
Clinical trials for BILIARY TRACT CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new BILIARY TRACT CARCINOMA trials appear
Sign up with your email to follow new studies for BILIARY TRACT CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for gallbladder cancer: drug duo targets tumors
Disease control Recruiting nowThis study tests a new drug called ZG005 combined with standard chemotherapy (gemcitabine and cisplatin) as a first treatment for people with advanced gallbladder cancer. The goal is to see if the combination shrinks tumors better than chemo alone. About 60 adults with confirmed …
Matched conditions: BILIARY TRACT CARCINOMA
Phase: PHASE2 • Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd • Aim: Disease control
Last updated May 16, 2026 23:50 UTC
-
Triple-drug attack shows promise against hard-to-treat bile duct cancer
Disease control Recruiting nowThis study tests a combination of three drugs—chemotherapy (GEMOX), a targeted therapy (donafenib), and an immunotherapy (tislelizumab)—in people with advanced biliary tract cancer that has spread. The goal is to see if this mix shrinks tumors and improves survival. About 93 adul…
Matched conditions: BILIARY TRACT CARCINOMA
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New cocktail of drugs shows promise for Tough-to-Treat bile duct cancer
Disease control Recruiting nowThis study tests a combination of four drugs (gemcitabine, cisplatin, zimberelimab, and quemliclustat) as a first treatment for people with advanced bile duct cancer that has not spread beyond the bile ducts. The goal is to see if this mix can slow cancer growth and help people l…
Matched conditions: BILIARY TRACT CARCINOMA
Phase: PHASE2 • Sponsor: Nataliya Uboha • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New drug AZD8205 tested in advanced cancers: hope for Hard-to-Treat tumors?
Disease control Recruiting nowThis study tests a new drug called AZD8205, alone or with other cancer drugs, in people with advanced solid tumors (like breast, ovarian, or lung cancer) that have spread or come back. The main goals are to check safety and find the right dose. About 460 adults whose cancer has n…
Matched conditions: BILIARY TRACT CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
Home cancer care trial aims to cut travel burden for florida patients
Symptom relief Recruiting nowThis study compares giving cancer treatment at home versus in a clinic for 27 adults with various cancers in the Florida Panhandle. The goal is to see if patients prefer home care and if it is safe. Participants will receive their usual cancer drugs either at home or in the clini…
Matched conditions: BILIARY TRACT CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 15, 2026 11:57 UTC